[Form 4] CLOROX CO /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Pierre R. Breber, a Director of Clorox Co. (CLX), reported transactions showing continued ownership and receipt of deferred compensation units. The filing shows indirect ownership of 9,000 shares through a family trust. On 08/29/2025 he acquired 502.2399 deferred stock units via dividend reinvestment under the Independent Directors' Deferred Compensation Plan, and on 09/30/2025 he received 263.5848 deferred stock units in lieu of quarterly director fees. The report states the deferred stock units are 1-for-1 and "will be settled 100% in Clorox stock" upon the reporting person's retirement or other termination of service as a Director. The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Positive

• Acquired 502.2399 DSUs on 08/29/2025 via dividend reinvestment
• Received 263.5848 DSUs on 09/30/2025 in lieu of quarterly director fees
• DSUs are 1-for-1 and will be settled 100% in Clorox stock upon termination
• Maintains indirect beneficial ownership of 9,000 shares through a family trust
• No sales or dispositions reported in this Form 4

Negative

• None.

Insights

Corporate Governance Analyst

Director increased equity exposure via deferred stock units and maintains 9,000 indirect shares.

The filing documents two non-cash equity accruals: 502.2399 DSUs on 08/29/2025 and 263.5848 DSUs on 09/30/2025, both added to the reporting person's deferred compensation balance. These units are described as 1-for-1 and will convert to Clorox common stock at termination of service, indicating retention of upside in company equity rather than immediate cash.

The report also records 9,000 shares beneficially owned indirectly through a family trust, which the filing lists separately from the director compensation units. No dispositions or sales are reported in this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Breber Pierre R

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								9,000	I(1)	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(2)	08/29/2025		A(3)	V	5.2141		(4)	(4)	Common Stock	5.2141	$0.0000	502.2399	D
Deferred Stock Units	(2)	09/30/2025		A(5)		263.5848		(4)	(4)	Common Stock	263.5848	$0.0000	765.8247	D

Explanation of Responses:

1. Indirectly owned through family trust.

2. 1-for-1

3. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

4. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

5. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

	By Jinho Joo, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Pierre R. Breber report on the Form 4 for CLX?

The Form 4 reports indirect ownership of 9,000 shares and acquisitions of deferred stock units: 502.2399 DSUs on 08/29/2025 and 263.5848 DSUs on 09/30/2025.

How will the deferred stock units reported by CLX Director be settled?

The filing states the deferred stock units are 1-for-1 and "will be settled 100% in Clorox stock" upon the reporting person's retirement or other termination of service.

Why were the deferred stock units granted on these dates?

The 502.2399 DSUs on 08/29/2025 were acquired through dividend reinvestment; the 263.5848 DSUs on 09/30/2025 were received in lieu of quarterly director fees.

Does the Form 4 show any stock sales by the reporting person?

No. The Form 4 discloses only acquisitions of deferred stock units and existing indirect ownership of 9,000 shares; no dispositions are reported.

When was the Form 4 signed and filed?

The signature by attorney-in-fact is dated 10/02/2025, and the earliest transaction date listed is 09/30/2025.